Principal Investigators

James DiCarlo


Jim DiCarlo is pioneering a novel, vision-based approach to treating anxiety by designing visual scenes that subtly shift emotional brain activity.

Evelina Fedorenko


Ev Fedorenko is working with McLean Hospital researchers and Nancy Kanwisher to reveal how differences in reasoning and language systems underlie schizophrenia’s cognitive symptoms.

Guoping Feng


Guoping Feng is using molecular and systems neuroscience to pursue the complex neurobiological mechanisms underlying psychiatric disorders.

John Gabrieli


John Gabrieli uses brain imaging to better understand changes in the human brain that accompany psychiatric disorders.

Mark Harnett


Mark Harnett is uncovering how ketamine reshapes brain circuits to deliver rapid antidepressant effects.

Nancy Kanwisher


Nancy Kanwisher collaborates with Ev Fedorenko and McLean scientists to identify neural signatures of impaired reasoning and disrupted inner voice in schizophrenia.

Susan Whitfield-Gabrieli


Research Affiliate Susan Whitfield-Gabrieli studies the brain basis of psychiatric disorders with the goal of translating this knowledge into clinical practice.

Feng Zhang


Feng Zhang is using CRISPR-based technologies to target genetic mutations linked to psychiatric disease.

Fellows

Cynthia Rais


Poitras Center Fellow, Harnett Lab

Cynthia Rais is studying the brain network and synaptic-level effect of a therapeutic dose of ketamine, a potential treatment for psychiatric diseases.